Tag Archives: Merck v. Olin-Mathieson

“Isolated” Natural Products Still in Purgatory Post-PTO Guidance?

Recently, a new class of antibiotic, teixobactin, was discovered in the soil in a Boston researcher’s backyard via a high throughput in situ screening chip that detected individual bacteria capable of growing in an uncultured state. The resulting isolates were … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , | 3 Comments